Physicians around the world are turning to cerebral/somatic oximetry as a means of identifying circulatory inadequacy in critical organ systems.
Nonin Medical’s neonatal and pediatric cerebral and somatic oximetry monitoring system offers absolute accuracy in the widest range of neonatal and pediatric clinical patients. Indicated for cerebral and somatic use in all patients weighing less than 40kg, the system aids the clinical care team with vital information in key tissue beds-enabling clinicians to quickly assess intervention needs.
The EQUANOX 8004CB and 8004CB-NA Neonatal/Pediatric Sensors were designed to be used in a variety of clinical settings. More...
Some settings include operating room, the neonatal intensive care unit and the pediatric intensive care unit. Select features of the EQUANOX™ Advance Neonatal/Pediatric Sensor Model 8004CB Series include:
Nonin’s exclusive EQUANOX technology reduces inaccuracies caused by light scattering effects from non-target tissue. More...
Dual emitters and dual detectors in the EQUANOX Advance sensor create pairs of reflected light paths through surface tissue and through the cerebral cortex, producing measurements that are minimally affected by intervening tissue or surface effects.
The light absorption information collected by the dual emitter/detector architecture is automatically incorporated into Nonin’s Dynamic Compensation™ light processing algorithm, to provide real tissue oxygenation saturation values based on the patient’s unique brain development characteristics.
Only Nonin EQUANOX uses two emitters and two detectors to provide cerebral cortex measurements that are minimally affected by intervening tissue or surface effects.
The EQUANOX Advance signal processing data provides the actual percent of oxygenated hemoglobin in the target tissue for display on the monitor.
The EQUANOX System is the first oximetry algorithm to automatically account for developing neonatal/pediatric brain tissue. More...
The optical properties of brain tissue change significantly during the first few months of life. The EQUANOX Advance Cerebral/Somatic Oximetry System effectively isolates targeted tissue and automatically takes into account the light attenuation changes caused by myelination variation, providing you with data you can act on.
To measure blood oxygen saturation levels, cerebral and somatic oximeters must separate the optical effects of blood from tissue.
The EQUANOX Advance 8004CB Series sensor has been designed from the ground up as a solution for neonatal/pediatric patients, More...
featuring light emitter/detector spacing that has been engineered and tested for neonate/infant/pediatric patients. This light path spacing is designed to reach, but not pass through, the vascularized cerebral cortex.
Whereas other cerebral oximetry systems require clinicians to enter information such as age and weight in order to obtain approximate brain development, Nonin’s Dynamic Compensation™ algorithm makes this step unnecessary and provides confidence that the data is patient specific. You simply place the sensor and instantly see the values. The displayed signal refreshes every 1.4 seconds; so, if the tissue saturation is changing, you will see it quickly.
Transport and easy positioning of monitoring systems are integral components of caring for neonates, infants and pediatric patients. The EQUANOX monitor is optimized for transport, weighing only two pounds.
With the EQUANOX Advance 8004CB Series sensor, clinicians have the ability to place the sensors in a variety of somatic positions. More...
In addition to cerebral placement, the 8400CB sensor can be placed in a variety of somatic locations.
With the EQUANOX Advance Cerebral /Somatic Oximetry System for neonatal/pediatric patients, clinicians no longer have to make do with yesterday’s engineering. More...
This system offers absolute accuracy—in either cerebral or somatic positions— regardless of body size, skin color, or features. Just as important, it sets new standards in portability, versatility and ease of use.
* Patent Pending